ESR1 and breast carcinoma: The most common classification of breast cancer divides it immunohistochemically into four subtypes: estrogen receptor (ER)-positive (+), ER-negative (−), human epidermal growth receptor (HER)+, and HER−, based on the hormonal subtype and their responsiveness towards the hormonal therapy.